{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:34:26Z","timestamp":1792625666097,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-25632-x","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T09:55:12Z","timestamp":1768902912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hyperpolypharmacy in patients with chronic kidney disease and its impact on clinical outcomes"],"prefix":"10.1038","volume":"16","author":[{"given":"Agathe","family":"Mouheb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Alencar de Pinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jacquelinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Laville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad A.","family":"Massy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Liabeuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol\u00e8ne M.","family":"Laville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"CKD-REIN STUDY GROUP","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Steering committee and coordinators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doroth\u00e9e","family":"Cannet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Combe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Fouque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Frimat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aghil\u00e8s","family":"Hamroun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves-Edouard","family":"Herpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriane","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Pascal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pecoits-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Schantsra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Stengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Hannedouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Moulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Combe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. P.","family":"Bourdenx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Delclaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Vendrely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Deroure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lacraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Lobbedez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Landru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Massy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Belenfant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Thervet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Urena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Delahousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Vela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Essig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Cl\u00e9ment","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Sekhri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Smati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Jamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Hacq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Panescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bellou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Frimat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Kamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"No\u00ebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Glowacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Maisonneuve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Azar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hourmant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Testa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Besnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Choukroun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Lambrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Burtey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Lebrun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Magnant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Laville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Fouque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Juillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Chazot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Zaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Kuentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"25632_CR1","doi-asserted-by":"crossref","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 105, S117\u2013S314 (2024).","DOI":"10.1016\/j.kint.2023.10.018"},{"key":"25632_CR2","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1053\/j.ajkd.2021.02.342","volume":"78","author":"SF Vondracek","year":"2021","unstructured":"Vondracek, S. F., Teitelbaum, I. & Kiser, T. H. Principles of kidney pharmacotherapy for the nephrologist: Core curriculum 2021. Am. J. Kidney Dis. 78, 442\u2013458 (2021).","journal-title":"Am. J. Kidney Dis."},{"key":"25632_CR3","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/ckj\/sfz072","volume":"12","author":"K Parker","year":"2019","unstructured":"Parker, K. & Wong, J. Is polypharmacy an increasing burden in chronic kidney disease? The German experience. Clin. Kidney J. 12, 659\u2013662 (2019).","journal-title":"Clin. Kidney J."},{"key":"25632_CR4","doi-asserted-by":"publisher","first-page":"841","DOI":"10.34067\/KID.0000000000000447","volume":"5","author":"IJ Oosting","year":"2024","unstructured":"Oosting, I. J. et al. Polypharmacy in patients with CKD: A systematic review and meta-analysis. Kidney360 5, 841\u2013850 (2024).","journal-title":"Kidney360"},{"key":"25632_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12882-015-0189-z","volume":"16","author":"SDS Fraser","year":"2015","unstructured":"Fraser, S. D. S. et al. The burden of comorbidity in people with chronic kidney disease stage 3: A cohort study. BMC Nephrol. 16, 193 (2015).","journal-title":"BMC Nephrol."},{"key":"25632_CR6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/ndt\/gfaa064","volume":"36","author":"S Hayward","year":"2021","unstructured":"Hayward, S. et al. International prescribing patterns and polypharmacy in older people with advanced chronic kidney disease: results from the European quality study. Nephrol. Dial. Transplant. 36, 503\u2013511 (2021).","journal-title":"Nephrol. Dial. Transplant."},{"key":"25632_CR7","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1093\/ckj\/sfab120","volume":"14","author":"MJM van Oosten","year":"2021","unstructured":"van Oosten, M. J. M. et al. Polypharmacy and medication use in patients with chronic kidney disease with and without kidney replacement therapy compared to matched controls. Clin. Kidney J. 14, 2497\u20132523 (2021).","journal-title":"Clin. Kidney J."},{"key":"25632_CR8","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/ckj\/sfz046","volume":"12","author":"IM Schmidt","year":"2019","unstructured":"Schmidt, I. M. et al. Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: The German chronic kidney disease study. Clin. Kidney J. 12, 663\u2013672 (2019).","journal-title":"Clin. Kidney J."},{"key":"25632_CR9","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/ki.2015.228","volume":"88","author":"M Tonelli","year":"2015","unstructured":"Tonelli, M. et al. Comorbidity as a driver of adverse outcomes in people with chronic kidney disease. Kidney Int. 88, 859\u2013866 (2015).","journal-title":"Kidney Int."},{"key":"25632_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2024.105465","volume":"124","author":"S Kim","year":"2024","unstructured":"Kim, S. et al. Global and regional prevalence of polypharmacy and related factors, 1997\u20132022: An umbrella review. Arch. Gerontol. Geriatr. 124, 105465 (2024).","journal-title":"Arch. Gerontol. Geriatr."},{"key":"25632_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0317907","volume":"20","author":"I Boateng","year":"2025","unstructured":"Boateng, I., Pascual, C. R., Grassby, P., Asghar, Z. & Ibrahim, K. The impact of polypharmacy on health outcomes in the aged: A retrospective cohort study. PLoS ONE 20, e0317907 (2025).","journal-title":"PLoS ONE"},{"key":"25632_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jamda.2019.10.022","volume":"21","author":"LE Davies","year":"2020","unstructured":"Davies, L. E. et al. Adverse outcomes of polypharmacy in older people: Systematic review of reviews. J. Am. Med. Dir. Assoc. 21, 181\u2013187 (2020).","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"25632_CR13","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1093\/ndt\/gft388","volume":"29","author":"B Stengel","year":"2014","unstructured":"Stengel, B. et al. The french chronic kidney disease-renal epidemiology and information network (CKD-REIN) cohort study. Nephrol. Dial. Transplant. 29, 1500\u20131507 (2014).","journal-title":"Nephrol. Dial. Transplant."},{"key":"25632_CR14","first-page":"1044","volume":"30","author":"X Girerd","year":"2001","unstructured":"Girerd, X. et al. Assessment of antihypertensive compliance using a self-administered questionnaire: Development and use in a hypertension clinic. Presse. Med. 30, 1044\u20131048 (2001).","journal-title":"Presse. Med."},{"key":"25632_CR15","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey, A. S. et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150, 604\u2013612 (2009).","journal-title":"Ann. Intern. Med."},{"key":"25632_CR16","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","volume":"356","author":"IR Edwards","year":"2000","unstructured":"Edwards, I. R. & Aronson, J. K. Adverse drug reactions: Definitions, diagnosis, and management. Lancet 356, 1255\u20131259 (2000).","journal-title":"Lancet"},{"key":"25632_CR17","unstructured":"World Health Organization Quality Assurance and Safet of Medecines Team. Safety of Medicines: A guide to detecting and reporting adverse drug reactions: Why health professionals need to take action. https:\/\/iris.who.int\/bitstream\/handle\/10665\/67378\/WHO_EDM_QSM_2002.2.pdf?sequence=1&isAllowed=y (2002)."},{"key":"25632_CR18","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.2215\/CJN.01030120","volume":"15","author":"SM Laville","year":"2020","unstructured":"Laville, S. M. et al. Adverse drug reactions in patients with CKD. Clin. J. Am. Soc. Nephrol. 15, 1090\u20131102 (2020).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"25632_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2515\/therapie\/2013016","volume":"68","author":"Y Arimone","year":"2013","unstructured":"Arimone, Y. et al. Updating the french method for the causality assessment of adverse drug reactions. Therapies 68, 69\u201376 (2013).","journal-title":"Therapies"},{"key":"25632_CR20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo, C. A. et al. A method for estimating the probability of adverse drug reactions. Clin. Pharmacol. Ther. 30, 239\u2013245 (1981).","journal-title":"Clin. Pharmacol. Ther."},{"key":"25632_CR21","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing (2021)."},{"key":"25632_CR22","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm, E. et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335, 806\u2013808 (2007).","journal-title":"BMJ"},{"key":"25632_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","volume":"12","author":"CP Kovesdy","year":"2022","unstructured":"Kovesdy, C. P. Epidemiology of chronic kidney disease: An update 2022. Kidney Int. Suppl. 12, 7\u201311 (2022).","journal-title":"Kidney Int. Suppl."},{"key":"25632_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0025-7125(05)70596-4","volume":"82","author":"JE Mulder","year":"1998","unstructured":"Mulder, J. E. Thyroid disease in women. Med. Clin. North Am. 82, 103\u2013125 (1998).","journal-title":"Med. Clin. North Am."},{"key":"25632_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S2215-0366(16)30348-0","volume":"4","author":"A Riecher-R\u00f6ssler","year":"2017","unstructured":"Riecher-R\u00f6ssler, A. Sex and gender differences in mental disorders. Lancet Psychiatry 4, 8\u20139 (2017).","journal-title":"Lancet Psychiatry"},{"key":"25632_CR26","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.joca.2024.04.002","volume":"32","author":"NA Segal","year":"2024","unstructured":"Segal, N. A., Nilges, J. M. & Oo, W. M. Sex differences in osteoarthritis prevalence, pain perception, physical function and therapeutics. Osteoarthr. Cartil. 32, 1045\u20131053 (2024).","journal-title":"Osteoarthr. Cartil."},{"key":"25632_CR27","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1093\/gerona\/60.9.1147","volume":"60","author":"A Corsonello","year":"2005","unstructured":"Corsonello, A. et al. Concealed renal failure and adverse drug reactions in older patients with type 2 diabetes mellitus. J. Gerontol. A. Biol. Sci. Med. Sci. 60, 1147\u20131151 (2005).","journal-title":"J. Gerontol. A. Biol. Sci. Med. Sci."},{"key":"25632_CR28","doi-asserted-by":"publisher","first-page":"18964","DOI":"10.1038\/s41598-020-75888-8","volume":"10","author":"TI Chang","year":"2020","unstructured":"Chang, T. I. et al. Polypharmacy, hospitalization, and mortality risk: A nationwide cohort study. Sci. Rep. 10, 18964 (2020).","journal-title":"Sci. Rep."},{"key":"25632_CR29","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.2215\/CJN.03940321","volume":"16","author":"H Kimura","year":"2021","unstructured":"Kimura, H. et al. Association of polypharmacy with kidney disease progression in adults with CKD. Clin. J. Am. Soc. Nephrol. 16, 1797\u20131804 (2021).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"25632_CR30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.18773\/austprescr.2020.033","volume":"43","author":"M Liacos","year":"2020","unstructured":"Liacos, M., Page, A. T. & Etherton-Beer, C. Deprescribing in older people. Aust. Prescr. 43, 114\u2013120 (2020).","journal-title":"Aust. Prescr."},{"key":"25632_CR31","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/ijpp\/riad025","volume":"31","author":"H Omuya","year":"2023","unstructured":"Omuya, H., Nickel, C., Wilson, P. & Chewning, B. A systematic review of randomised-controlled trials on deprescribing outcomes in older adults with polypharmacy. Int. J. Pharm. Pract. 31, 349\u2013368 (2023).","journal-title":"Int. J. Pharm. Pract."},{"key":"25632_CR32","first-page":"597","volume":"38","author":"A Mouheb","year":"2025","unstructured":"Mouheb, A. et al. Association between urate-lowering therapy and kidney failure in patients with chronic kidney disease. J. Nephrol. 38, 597\u2013607 (2025).","journal-title":"J. Nephrol."},{"key":"25632_CR33","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1111\/bcp.14713","volume":"87","author":"S Liabeuf","year":"2021","unstructured":"Liabeuf, S. et al. Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease: The CKD-REIN cohort study. Br. J. Clin. Pharmacol. 87, 2967\u20132976 (2021).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"25632_CR34","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.19283","author":"A Mouheb","year":"2024","unstructured":"Mouheb, A. et al. The anticholinergic burden in patients with chronic kidney disease: Patterns, risk factors, and the link with cognitive impairment. J. Am. Geriatr. Soc. https:\/\/doi.org\/10.1111\/jgs.19283 (2024).","journal-title":"J. Am. Geriatr. Soc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25632-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25632-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25632-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:10:17Z","timestamp":1769213417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25632-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["25632"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-25632-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"assertion":[{"value":"10 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A.M., S.L., S.M.L., M.M., M.L. have nothing to declare. N.A.P. declare financial support from pharmaceutical companies involved in the CKD-REIN study\u2019s public\u2013private partnership: Fresenius Medical Care, GlaxoSmithKline (GSK), Vifor France, and Boehringer Ingelheim; all the grants were made to Paris Saclay University. Z.A.M. reports having received grants for CKD-REIN and other research projects from Amgen, Baxter, Fresenius Medical Care, GlaxoSmithKline, Merck Sharp & Dohme-Chibret, Sanofi- Genzyme, Lilly, Otsuka, AstraZeneca, Vifor and the French government, as well as fees and grants to charities from AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline.  However, none of the authors has any direct competing financial and\/or non-financial interests to disclose in relation to the research presented in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2653"}}